This compound is primarily used in the pharmaceutical industry as a chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group, enhances the biological activity and metabolic stability of the final drug molecules. It is particularly valuable in the development of enantiomerically pure drugs, where the (S)-configuration plays a critical role in achieving the desired therapeutic effect. Additionally, it finds applications in organic synthesis as a building block for creating complex molecules with specific stereochemistry, often employed in the production of agrochemicals and specialty chemicals. Its unique properties make it a versatile reagent in asymmetric synthesis and catalysis.